logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Naoki Kotani

Osaka Institute of Technology
H指数:29
被引数:2,800

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase Ib dose escalation study evaluating the mutant selective PI3K-alpha inhibitor GDC-0077 (G) in combination with letrozole (L) with and without palbociclib (P) in patients with PIK3CA-mutant HR+/HER2-breast cancer
CANCER RESEARCH
IF16.6
2020-02-152
PRE
Jhaveri, Komal; Kalinsky, Kevin; Bedard, Philippe; Cervantes, Andres; Saura, Cristina; Krop, Ian; Hamilton, Erika; Schmid, Peter; Varga, Andrea; Turner, Nick; Italiano, Antoine; Gambardella, Valentina; Veitch, Zachary; Oliveira, Mafalda; Dickmann, Leslie; Kotani, Naoki; Kapp, Amy; Hutchinson, Katie; Royer-Joo, Stephanie; Vaze, Anjali; Schutzman, Jennifer; Juric, Dejan
A first-in-human phase Ia dose escalation study of GDC-0077, a p110a-selective and mutant-degrading PI3K inhibitor, in patients with PIK3CA-mutant solid tumors

p110a-selective和突变型降解PI3K抑制剂GDC-0077在PIK3CA-mutant实体瘤患者中的首次人类Ia期剂量递增研究

CANCER RESEARCH
IF16.6
2020-02-1513
PRE
Juric, Dejan; Kalinsky, Kevin; Oliveira, Mafalda; Cervantes, Andres; Bedard, Philippe; Krop, Ian; Hamilton, Erika; Schmid, Peter; Varga, Andrea; Turner, Nick; Italiano, Antoine; Saura, Cristina; Gambardella, Valentina; Veitch, Zachary; Dickmann, Leslie; Kotani, Naoki; Fredrickson, Jill; Kapp, Amy; Hutchinson, Katie; Royer-Joo, Stephanie; Vaze, Anjali; Schutzman, Jennifer; Jhaveri, Komal
Phase Ia/Ib study of taselisib (GDC-0032), a potent and selective phosphoinositide 3-kinase inhibitor, in Japanese patients with advanced solid tumors or hormone receptor-positive locally advanced or metastatic breast cancer (JO29196 study)
CANCER RESEARCH
IF16.6
2016-02-150
PRE
Kobayashi, T.; Nakano, K.; Tomomatsu, J.; Nara, E.; Ito, Y.; Kobayashi, K.; Fukada, I.; Araki, K.; Shimomura, A.; Shimoi, T.; Kodaira, M.; Yunokawa, M.; Yonemori, K.; Shimizu, C.; Nakamura, K.; Kotani, N.; Inatani, M.; Tamura, K.; Takahashi, S.

研究方向

暂未获取到该数据
A
A Matsuki
H 指数:35论文数:717被引数:5,334
H
Hiroshi Hashimoto
H 指数:91论文数:1,472被引数:3.1万
M
Masatoshi Muraoka
H 指数:24论文数:68被引数:2,859
D
Daniel I. Sessler
H 指数:147论文数:1,492被引数:9.3万
N
Norio Akaike
H 指数:0论文数:0被引数:1
T
Tetsuya Kushikata
H 指数:27论文数:170被引数:2,656
K
Kiku Nonaka
H 指数:11论文数:33被引数:298
M
Masahito Wakita
H 指数:13论文数:42被引数:584
I
Il‐Sung Jang
H 指数:30论文数:118被引数:2,869
S
Satoshi Takahashi
H 指数:45论文数:415被引数:7,384